about
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...
Read More
27.28
-1.37
(-4.78%)
368.4K
XNAS Volume
XNAS 11 Mar, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Oculis Holding AG took place on 11 Mar 2026, for the purpose of Oculis Holding AG Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Oculis Holding AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..